BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lieber CS, Leo MA, Cao Q, Ren C, DeCarli LM. Silymarin retards the progression of alcohol-induced hepatic fibrosis in baboons. J Clin Gastroenterol. 2003;37:336-339. [PMID: 14506392 DOI: 10.1097/00004836-200310000-00013] [Cited by in Crossref: 101] [Cited by in F6Publishing: 81] [Article Influence: 5.6] [Reference Citation Analysis]
Number Citing Articles
1 Markell MS. Potential benefits of complementary medicine modalities in patients with chronic kidney disease. Adv Chronic Kidney Dis 2005;12:292-9. [PMID: 16010644 DOI: 10.1016/j.ackd.2005.03.004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
2 Webster CR, Cooper J. Therapeutic use of cytoprotective agents in canine and feline hepatobiliary disease. Vet Clin North Am Small Anim Pract 2009;39:631-52. [PMID: 19524797 DOI: 10.1016/j.cvsm.2009.02.002] [Cited by in Crossref: 32] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
3 Singab AN, Ayoub NA, Ali EN, Mostafa NM. Antioxidant and hepatoprotective activities of Egyptian moraceous plants against carbon tetrachloride-induced oxidative stress and liver damage in rats. Pharm Biol 2010;48:1255-64. [PMID: 20839909 DOI: 10.3109/13880201003730659] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]
4 Song Z, Deaciuc I, Song M, Lee DY, Liu Y, Ji X, McClain C. Silymarin protects against acute ethanol-induced hepatotoxicity in mice. Alcohol Clin Exp Res. 2006;30:407-413. [PMID: 16499481 DOI: 10.1111/j.1530-0277.2006.00063.x] [Cited by in Crossref: 112] [Cited by in F6Publishing: 103] [Article Influence: 7.0] [Reference Citation Analysis]
5 Wang JH, Choi MK, Shin JW, Hwang SY, Son CG. Antifibrotic effects of Artemisia capillaris and Artemisia iwayomogi in a carbon tetrachloride-induced chronic hepatic fibrosis animal model. J Ethnopharmacol 2012;140:179-85. [PMID: 22265746 DOI: 10.1016/j.jep.2012.01.007] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
6 Saller R, Melzer J, Reichling J, Brignoli R, Meier R. An updated systematic review of the pharmacology of silymarin. Forsch Komplementmed 2007;14:70-80. [PMID: 17464157 DOI: 10.1159/000100581] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 3.0] [Reference Citation Analysis]
7 Dryden GW, Song M, McClain C. Polyphenols and gastrointestinal diseases. Curr Opin Gastroenterol 2006;22:165-70. [PMID: 16462174 DOI: 10.1097/01.mog.0000208463.69266.8c] [Cited by in Crossref: 50] [Cited by in F6Publishing: 42] [Article Influence: 3.1] [Reference Citation Analysis]
8 Rockey DC. New therapies in hepatitis C virus and chronic liver disease: antifibrotics. Clin Liver Dis 2006;10:881-900. [PMID: 17164123 DOI: 10.1016/j.cld.2006.08.019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
9 Pais P, D'Amato M. In vivo efficacy study of milk thistle extract (ETHIS-094™) in STAM™ model of nonalcoholic steatohepatitis. Drugs R D 2014;14:291-9. [PMID: 25404123 DOI: 10.1007/s40268-014-0068-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
10 Saad RA, El-bab MF, Shalaby AA. Attenuation of acute and chronic liver injury by melatonin in rats. Journal of Taibah University for Science 2018;7:88-96. [DOI: 10.1016/j.jtusci.2013.04.008] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 3.8] [Reference Citation Analysis]
11 Crittenden NE, McClain C. Management of patients with moderate alcoholic liver disease. Clin Liver Dis (Hoboken) 2013;2:76-9. [PMID: 30992829 DOI: 10.1002/cld.190] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
12 El-Zayadi AR, Attia M, Badran HM, El-Tawil A, Zalata K, Barakat E, Selim O, El-Nakeeb A, Saied A. Non-interferon-based therapy: an option for amelioration of necro-inflammation in hepatitis C patients who cannot afford interferon therapy. Liver Int 2005;25:746-51. [PMID: 15998425 DOI: 10.1111/j.1478-3231.2005.01110.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
13 Batey RG, Salmond SJ, Bensoussan A. Complementary and alternative medicine in the treatment of chronic liver disease. Curr Gastroenterol Rep 2005;7:63-70. [DOI: 10.1007/s11894-005-0068-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
14 Rockey DC, Friedman SL. Hepatic Fibrosis and Cirrhosis. Zakim and Boyer's Hepatology. Elsevier; 2006. pp. 87-109. [DOI: 10.1016/b978-1-4160-3258-8.50011-5] [Cited by in Crossref: 8] [Article Influence: 0.5] [Reference Citation Analysis]
15 Pagonis TA, Koukoulis GN, Hadjichristodoulou CS, Toli PN, Angelopoulos NV. Multivitamins and phospholipids complex protects the hepatic cells from androgenic-anabolic-steroids-induced toxicity. Clinical Toxicology 2008;46:57-66. [DOI: 10.1080/15563650701590910] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
16 Chon S, Kim N. Evaluation of silymarin in the treatment on asymptomatic Giardia infections in dogs. Parasitol Res 2005;97:445-51. [DOI: 10.1007/s00436-005-1462-z] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
17 Wang L, He FL, Liu FQ, Yue ZD, Zhao HW. Establishment of a hepatic cirrhosis and portal hypertension model by hepatic arterial perfusion with 80% alcohol. World J Gastroenterol 2015; 21(32): 9544-9553 [PMID: 26327762 DOI: 10.3748/wjg.v21.i32.9544] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
18 Saha P, Talukdar AD, Nath R, Sarker SD, Nahar L, Sahu J, Choudhury MD. Role of Natural Phenolics in Hepatoprotection: A Mechanistic Review and Analysis of Regulatory Network of Associated Genes. Front Pharmacol 2019;10:509. [PMID: 31178720 DOI: 10.3389/fphar.2019.00509] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
19 Lans C, Turner N, Brauer G, Lourenco G, Georges K. Ethnoveterinary medicines used for horses in Trinidad and in British Columbia, Canada. J Ethnobiol Ethnomed 2006;2:31. [PMID: 16893454 DOI: 10.1186/1746-4269-2-31] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
20 Ceni E, Mello T, Galli A. Pathogenesis of alcoholic liver disease: Role of oxidative metabolism. World J Gastroenterol 2014; 20(47): 17756-17772 [PMID: 25548474 DOI: 10.3748/wjg.v20.i47.17756] [Cited by in CrossRef: 223] [Cited by in F6Publishing: 201] [Article Influence: 27.9] [Reference Citation Analysis]
21 Rockey DC. Current and future anti-fibrotic therapies for chronic liver disease. Clin Liver Dis 2008;12:939-62, xi. [PMID: 18984475 DOI: 10.1016/j.cld.2008.07.011] [Cited by in Crossref: 112] [Cited by in F6Publishing: 108] [Article Influence: 8.6] [Reference Citation Analysis]
22 Lieber CS. Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. Alcohol 2004;34:9-19. [PMID: 15670660 DOI: 10.1016/j.alcohol.2004.07.008] [Cited by in Crossref: 419] [Cited by in F6Publishing: 381] [Article Influence: 23.3] [Reference Citation Analysis]
23 Federico A, Dallio M, Loguercio C. Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years. Molecules 2017;22:E191. [PMID: 28125040 DOI: 10.3390/molecules22020191] [Cited by in Crossref: 132] [Cited by in F6Publishing: 109] [Article Influence: 26.4] [Reference Citation Analysis]
24 Clarke C, Baghdadi H, Howie AF, Mason JI, Walker SW, Beckett GJ. Selenium supplementation attenuates procollagen-1 and interleukin-8 production in fat-loaded human C3A hepatoblastoma cells treated with TGFbeta1. Biochim Biophys Acta 2010;1800:611-8. [PMID: 20188144 DOI: 10.1016/j.bbagen.2010.02.007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
25 Lívero FA, Acco A. Molecular basis of alcoholic fatty liver disease: From incidence to treatment. Hepatol Res. 2016;46:111-123. [PMID: 26417962 DOI: 10.1111/hepr.12594] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 5.1] [Reference Citation Analysis]
26 Rambaldi A, Jacobs BP, Iaquinto G, Gluud C. Milk thistle for alcoholic and/or hepatitis B or C liver diseases--a systematic cochrane hepato-biliary group review with meta-analyses of randomized clinical trials. Am J Gastroenterol 2005;100:2583-91. [PMID: 16279916 DOI: 10.1111/j.1572-0241.2005.00262.x] [Cited by in Crossref: 77] [Cited by in F6Publishing: 60] [Article Influence: 4.5] [Reference Citation Analysis]
27 Frazier TH, Stocker AM, Kershner NA, Marsano LS, McClain CJ. Treatment of alcoholic liver disease. Therap Adv Gastroenterol. 2011;4:63-81. [PMID: 21317995 DOI: 10.1177/1756283x10378925] [Cited by in Crossref: 84] [Cited by in F6Publishing: 48] [Article Influence: 7.6] [Reference Citation Analysis]
28 Cui W, Gu F, Hu KQ. Effects and mechanisms of silibinin on human hepatocellular carcinoma xenografts in nude mice. World J Gastroenterol 2009; 15(16): 1943-1950 [PMID: 19399925 DOI: 10.3748/wjg.15.1943] [Cited by in CrossRef: 45] [Cited by in F6Publishing: 41] [Article Influence: 3.5] [Reference Citation Analysis]
29 Lin CJ, Chiu CC, Chen YC, Chen ML, Hsu TC, Tzang BS. Taurine Attenuates Hepatic Inflammation in Chronic Alcohol-Fed Rats Through Inhibition of TLR4/MyD88 Signaling. J Med Food 2015;18:1291-8. [PMID: 26090712 DOI: 10.1089/jmf.2014.3408] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]
30 Rockey DC. Translating an understanding of the pathogenesis of hepatic fibrosis to novel therapies. Clin Gastroenterol Hepatol. 2013;11:224-31.e1-5. [PMID: 23305825 DOI: 10.1016/j.cgh.2013.01.005] [Cited by in Crossref: 61] [Cited by in F6Publishing: 53] [Article Influence: 6.8] [Reference Citation Analysis]
31 Gasnier C, Laurant C, Decroix-Laporte C, Mesnage R, Clair E, Travert C, Séralini GE. Defined plant extracts can protect human cells against combined xenobiotic effects. J Occup Med Toxicol 2011;6:3. [PMID: 21251308 DOI: 10.1186/1745-6673-6-3] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
32 Yassin NYS, AbouZid SF, El-Kalaawy AM, Ali TM, Almehmadi MM, Ahmed OM. Silybum marianum total extract, silymarin and silibinin abate hepatocarcinogenesis and hepatocellular carcinoma growth via modulation of the HGF/c-Met, Wnt/β-catenin, and PI3K/Akt/mTOR signaling pathways. Biomed Pharmacother 2021;145:112409. [PMID: 34781148 DOI: 10.1016/j.biopha.2021.112409] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
33 Lama S, Vanacore D, Diano N, Nicolucci C, Errico S, Dallio M, Federico A, Loguercio C, Stiuso P. Ameliorative effect of Silybin on bisphenol A induced oxidative stress, cell proliferation and steroid hormones oxidation in HepG2 cell cultures. Sci Rep 2019;9:3228. [PMID: 30824780 DOI: 10.1038/s41598-019-40105-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
34 Duval F, Moreno-Cuevas JE, González-Garza MT, Rodríguez-Montalvo C, Cruz-Vega DE. Protective mechanisms of medicinal plants targeting hepatic stellate cell activation and extracellular matrix deposition in liver fibrosis. Chin Med 2014;9:27. [PMID: 25606051 DOI: 10.1186/s13020-014-0027-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
35 Rambaldi A, Jacobs BP, Gluud C. Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases. Cochrane Database Syst Rev. 2007;CD003620. [PMID: 17943794 DOI: 10.1002/14651858.cd003620.pub3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
36 Hanje AJ, Fortune B, Song M, Hill D, McClain C. The use of selected nutrition supplements and complementary and alternative medicine in liver disease. Nutr Clin Pract 2006;21:255-72. [PMID: 16772543 DOI: 10.1177/0115426506021003255] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 2.4] [Reference Citation Analysis]
37 Mahli A, Koch A, Czech B, Peterburs P, Lechner A, Haunschild J, Müller M, Hellerbrand C. Hepatoprotective effect of oral application of a silymarin extract in carbon tetrachloride-induced hepatotoxicity in rats. Clin Phytosci 2015;1. [DOI: 10.1186/s40816-015-0006-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
38 Ghorbani Z, Hajizadeh M, Hekmatdoost A. Dietary supplementation in patients with alcoholic liver disease: a review on current evidence. Hepatobiliary & Pancreatic Diseases International 2016;15:348-60. [DOI: 10.1016/s1499-3872(16)60096-6] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 3.7] [Reference Citation Analysis]
39 Bayram D, Çetin E, Kara M, Özgöçmen M, Candan I. The apoptotic effects of silibinin on MDA-MB-231 and MCF-7 human breast carcinoma cells. Hum Exp Toxicol 2017;36:573-86. [DOI: 10.1177/0960327116658105] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
40 Rockey DC, Friedman SL. Hepatic Fibrosis and Cirrhosis. Zakim and Boyer's Hepatology. Elsevier; 2012. pp. 64-85. [DOI: 10.1016/b978-1-4377-0881-3.00005-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
41 Pan X, Ma X, Jiang Y, Wen J, Yang L, Chen D, Cao X, Peng C. A Comprehensive Review of Natural Products against Liver Fibrosis: Flavonoids, Quinones, Lignans, Phenols, and Acids. Evid Based Complement Alternat Med 2020;2020:7171498. [PMID: 33082829 DOI: 10.1155/2020/7171498] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
42 Rockey DC. Antifibrotic therapy in chronic liver disease. Clin Gastroenterol Hepatol. 2005;3:95-107. [PMID: 15704042 DOI: 10.1016/s1542-3565(04)00445-8] [Cited by in Crossref: 82] [Cited by in F6Publishing: 45] [Article Influence: 4.8] [Reference Citation Analysis]
43 Li Y, Martin RC 2nd. Herbal medicine and hepatocellular carcinoma: applications and challenges. Evid Based Complement Alternat Med 2011;2011:541209. [PMID: 21799681 DOI: 10.1093/ecam/neq044] [Cited by in Crossref: 21] [Cited by in F6Publishing: 30] [Article Influence: 1.9] [Reference Citation Analysis]
44 Baliga MS, Shivashankara AR, Venkatesh S, Bhat HP, Palatty PL, Bhandari G, Rao S. Phytochemicals in the Prevention of Ethanol-Induced Hepatotoxicity. Dietary Interventions in Liver Disease. Elsevier; 2019. pp. 79-89. [DOI: 10.1016/b978-0-12-814466-4.00007-0] [Cited by in Crossref: 4] [Article Influence: 1.3] [Reference Citation Analysis]
45 Kim MS, Ong M, Qu X. Optimal management for alcoholic liver disease: Conventional medications, natural therapy or combination? World J Gastroenterol 2016; 22(1): 8-23 [PMID: 26755857 DOI: 10.3748/wjg.v22.i1.8] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 32] [Article Influence: 5.2] [Reference Citation Analysis]
46 Ma Q, Wang LH, Jiang JG. Hepatoprotective effect of flavonoids from Cirsium japonicum DC on hepatotoxicity in comparison with silymarin. Food Funct 2016;7:2179-84. [PMID: 27094923 DOI: 10.1039/c6fo00068a] [Cited by in Crossref: 24] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
47 Cruz A, Padillo FJ, Torres E, Navarrete CM, Muñoz-Castañeda JR, Caballero FJ, Briceño J, Marchal T, Túnez I, Montilla P, Pera C, Muntané J. Melatonin prevents experimental liver cirrhosis induced by thioacetamide in rats. J Pineal Res 2005;39:143-50. [PMID: 16098091 DOI: 10.1111/j.1600-079X.2005.00227.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
48 Koltai T, Fliegel L. Role of Silymarin in Cancer Treatment: Facts, Hypotheses, and Questions. J Evid Based Integr Med 2022;27:2515690X211068826. [PMID: 35018864 DOI: 10.1177/2515690X211068826] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
49 Lee HA, Chang Y, Sung PS, Yoon EL, Lee HW, Yoo JJ, Lee YS, An J, Song DS, Cho YY, Kim SU, Kim YJ. Therapeutic mechanisms and beneficial effects of non-antidiabetic drugs in chronic liver diseases. Clin Mol Hepatol 2022;28:425-72. [PMID: 35850495 DOI: 10.3350/cmh.2022.0186] [Reference Citation Analysis]
50 N/A. N/A. Shijie Huaren Xiaohua Zazhi 2004; 12(10): 2472-2475 [DOI: 10.11569/wcjd.v12.i10.2472] [Reference Citation Analysis]
51 Takke A, Shende P. Nanotherapeutic silibinin: An insight of phytomedicine in healthcare reformation. Nanomedicine: Nanotechnology, Biology and Medicine 2019;21:102057. [DOI: 10.1016/j.nano.2019.102057] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 5.7] [Reference Citation Analysis]
52 Ball KR, Kowdley KV. A review of Silybum marianum (milk thistle) as a treatment for alcoholic liver disease. J Clin Gastroenterol 2005;39:520-8. [PMID: 15942440 DOI: 10.1097/01.mcg.0000165668.79530.a0] [Cited by in Crossref: 33] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
53 Fahmy Ahmed A, Fouad Mahmoud M, Arafat Ouf M, Abd El-fathaah E. Aminoguanidine potentiates the hepatoprotective effect of Silymarin in CCL4 treated rats. Annals of Hepatology 2011;10:207-15. [DOI: 10.1016/s1665-2681(19)31570-4] [Cited by in Crossref: 20] [Article Influence: 1.8] [Reference Citation Analysis]
54 Tighe SP, Akhtar D, Iqbal U, Ahmed A. Chronic Liver Disease and Silymarin: A Biochemical and Clinical Review. J Clin Transl Hepatol 2020;8:454-8. [PMID: 33447529 DOI: 10.14218/JCTH.2020.00012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
55 Ezhilarasan D. Oxidative stress is bane in chronic liver diseases: Clinical and experimental perspective. Arab J Gastroenterol 2018;19:56-64. [PMID: 29853428 DOI: 10.1016/j.ajg.2018.03.002] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 9.0] [Reference Citation Analysis]
56 Shin JW, Son JY, Oh SM, Han SH, Wang JH, Cho JH, Cho CK, Yoo HS, Lee YW, Lee MM, Hu XP, Son CG. An herbal formula, CGX, exerts hepatotherapeutic effects on dimethylnitrosamine-induced chronic liver injury model in rats. World J Gastroenterol 2006; 12(38): 6142-6148 [PMID: 17036385 DOI: 10.3748/wjg.v12.i38.6142] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
57 Janel N, Noll C. Protection and Reversal of Hepatic Fibrosis by Polyphenols. Polyphenols in Human Health and Disease. Elsevier; 2014. pp. 665-79. [DOI: 10.1016/b978-0-12-398456-2.00051-7] [Cited by in Crossref: 4] [Article Influence: 0.5] [Reference Citation Analysis]
58 Elmahdy NA, Sokar SS, Salem ML, Sarhan NI, Abou-elela SH. Anti-fibrotic potential of human umbilical cord mononuclear cells and mouse bone marrow cells in CCl 4 - induced liver fibrosis in mice. Biomedicine & Pharmacotherapy 2017;89:1378-86. [DOI: 10.1016/j.biopha.2017.03.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
59 Loguercio C, Festi D. Silybin and the liver: From basic research to clinical practice. World J Gastroenterol 2011; 17(18): 2288-2301 [PMID: 21633595 DOI: 10.3748/wjg.v17.i18.2288] [Cited by in CrossRef: 211] [Cited by in F6Publishing: 183] [Article Influence: 19.2] [Reference Citation Analysis]
60 Su CH, Chen LJ, Liao JF, Cheng JT. Increase of phosphatase and tensin homolog by silymarin to inhibit human pharynx squamous cancer. J Med Food. 2013;16:778-784. [PMID: 23909904 DOI: 10.1089/jmf.2012.2534] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
61 Gillessen A, Schmidt HH. Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review. Adv Ther 2020;37:1279-301. [PMID: 32065376 DOI: 10.1007/s12325-020-01251-y] [Cited by in Crossref: 64] [Cited by in F6Publishing: 51] [Article Influence: 32.0] [Reference Citation Analysis]
62 Hackett ES, Twedt DC, Gustafson DL. Milk thistle and its derivative compounds: a review of opportunities for treatment of liver disease. J Vet Intern Med. 2013;27:10-16. [PMID: 23140176 DOI: 10.1111/jvim.12002] [Cited by in Crossref: 55] [Cited by in F6Publishing: 45] [Article Influence: 5.5] [Reference Citation Analysis]
63 Teng Y, Sun CH, Li G, Sun G, Nomachi Y, Yokota J, Yoshioka S, Gang J, Jiao S, Zhang Y, Miyamura M. Protective effects of Flos lonicera extract on acute liver injury by dimethylnitrosamine-induced in rats. J Nat Med 2010;64:288-94. [PMID: 20306146 DOI: 10.1007/s11418-010-0405-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
64 Lah JJ, Cui W, Hu KQ. Effects and mechanisms of silibinin on human hepatoma cell lines. World J Gastroenterol 2007; 13(40): 5299-5305 [PMID: 17879397 DOI: 10.3748/wjg.v13.i40.5299] [Cited by in CrossRef: 65] [Cited by in F6Publishing: 58] [Article Influence: 4.3] [Reference Citation Analysis]
65 Reisinger N, Schaumberger S, Nagl V, Hessenberger S, Schatzmayr G. Milk thistle extract and silymarin inhibit lipopolysaccharide induced lamellar separation of hoof explants in vitro. Toxins (Basel) 2014;6:2962-74. [PMID: 25290524 DOI: 10.3390/toxins6102962] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
66 Bardazzi G, Merluzzi J, Voller F, Fontana A, Abenavoli L, Leggio L, Addolorato G. Complementary medicine for alcohol dependence in Italian services: A mail questionnaire. Complementary Therapies in Clinical Practice 2006;12:216-21. [DOI: 10.1016/j.ctcp.2005.12.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
67 Sayan M, Karabulut D, Özdamar S. Assessment of the protective and therapeutic effect of melatonin against thioacetamide-induced acute liver damage. J Biochem Mol Toxicol 2020;34:e22450. [PMID: 31967703 DOI: 10.1002/jbt.22450] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
68 O'Shea RS, McCullough AJ. Treatment of alcoholic hepatitis. Clin Liver Dis 2005;9:103-34. [PMID: 15763232 DOI: 10.1016/j.cld.2004.11.004] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
69 Abenavoli L, Capasso R, Milic N, Capasso F. Milk thistle in liver diseases: past, present, future. Phytother Res 2010;24:1423-32. [DOI: 10.1002/ptr.3207] [Cited by in Crossref: 289] [Cited by in F6Publishing: 244] [Article Influence: 24.1] [Reference Citation Analysis]
70 Zhao ZW, Chang JC, Lin LW, Tsai FH, Chang HC, Wu CR. Comparison of the Hepatoprotective Effects of Four Endemic Cirsium Species Extracts from Taiwan on CCl₄-Induced Acute Liver Damage in C57BL/6 Mice. Int J Mol Sci 2018;19:E1329. [PMID: 29710853 DOI: 10.3390/ijms19051329] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
71 Lynch KD, Montonye ML, Tian DD, Arman T, Oyanna VO, Bechtold BJ, Graf TN, Oberlies NH, Paine MF, Clarke JD. Hepatic organic anion transporting polypeptides mediate disposition of milk thistle flavonolignans and pharmacokinetic silymarin-drug interactions. Phytother Res 2021;35:3286-97. [PMID: 33587330 DOI: 10.1002/ptr.7049] [Reference Citation Analysis]
72 Shivashankara AR, Venkatesh S, Bhat HP, Palatty PL, Baliga MS. Can Phytochemicals be Effective in Preventing Ethanol-Induced Hepatotoxicity in the Geriatric Population? An Evidence-Based Revisit. Foods and Dietary Supplements in the Prevention and Treatment of Disease in Older Adults. Elsevier; 2015. pp. 163-70. [DOI: 10.1016/b978-0-12-418680-4.00017-8] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
73 N/A. N/A. Shijie Huaren Xiaohua Zazhi 2005; 13(3): 367-370 [DOI: 10.11569/wcjd.v13.i3.367] [Reference Citation Analysis]
74 Cheng KC, Asakawa A, Li YX, Chung HH, Amitani H, Ueki T, Cheng JT, Inui A. Silymarin induces insulin resistance through an increase of phosphatase and tensin homolog in Wistar rats. PLoS One 2014;9:e84550. [PMID: 24404172 DOI: 10.1371/journal.pone.0084550] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
75 Dean AJ. Natural and complementary therapies for substance use disorders. Current Opinion in Psychiatry 2005;18:271-6. [DOI: 10.1097/01.yco.0000165597.06176.71] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
76 Lee SW, Yang KM, Kim JK, Nam BH, Lee CM, Jeong MH, Seo SY, Kim GY, Jo WS. Effects of White Radish (Raphanus sativus) Enzyme Extract on Hepatotoxicity. Toxicol Res 2012;28:165-72. [PMID: 24278606 DOI: 10.5487/TR.2012.28.3.165] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
77 Mayer KE, Myers RP, Lee SS. Silymarin treatment of viral hepatitis: a systematic review. J Viral Hepat. 2005;12:559-567. [PMID: 16255756 DOI: 10.1111/j.1365-2893.2005.00636.x] [Cited by in Crossref: 102] [Cited by in F6Publishing: 91] [Article Influence: 6.0] [Reference Citation Analysis]
78 Jia R, Cao L, Du J, Xu P, Jeney G, Yin G. The protective effect of silymarin on the carbon tetrachloride (CCl4)-induced liver injury in common carp (Cyprinus carpio). In Vitro Cell Dev Biol -Animal 2013;49:155-61. [DOI: 10.1007/s11626-013-9587-3] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 3.7] [Reference Citation Analysis]
79 Lieber CS. New concepts of the pathogenesis of alcoholic liver disease lead to novel treatments. Curr Gastroenterol Rep. 2004;6:60-65. [PMID: 14720455 DOI: 10.1007/s11894-004-0027-0] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 2.8] [Reference Citation Analysis]
80 Mata-Santos HA, Dutra FF, Rocha CC, Lino FG, Xavier FR, Chinalia LA, Hossy BH, Castelo-Branco MT, Teodoro AJ, Paiva CN. Silymarin reduces profibrogenic cytokines and reverses hepatic fibrosis in chronic murine schistosomiasis. Antimicrob Agents Chemother. 2014;58:2076-2083. [PMID: 24449779 DOI: 10.1128/aac.01936-13] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
81 Corchete P. Silybum marianum (L.) Gaertn: the Source of Silymarin. In: Ramawat K, Merillon J, editors. Bioactive Molecules and Medicinal Plants. Berlin: Springer Berlin Heidelberg; 2008. pp. 123-48. [DOI: 10.1007/978-3-540-74603-4_6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
82 Rambaldi A, Jacobs BP, Iaquinto G, Gluud C. Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases. Cochrane Database Syst Rev. 2005;CD003620. [PMID: 15846671 DOI: 10.1002/14651858.cd003620.pub2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
83 Abdel Salam OM, Sleem AA, Shafee N. Hepatoprotective effects of the nitric oxide donor isosorbide-5-mononitrate alone and in combination with the natural hepatoprotectant, silymarin, on carbon tetrachloride-induced hepatic injury in rats. Inflammopharmacology 2010;18:87-94. [PMID: 20069380 DOI: 10.1007/s10787-009-0027-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
84 Zeng MD, Li YM, Chen CW, Lu LG, Fan JG, Wang BY, Mao YM. Guidelines for the diagnosis and treatment of alcoholic liver disease. J Dig Dis. 2008;9:113-116. [PMID: 18419646 DOI: 10.1111/j.1751-2980.2008.00332.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
85 Yadav NP, Pal A, Shanker K, Bawankule DU, Gupta AK, Darokar MP, S Khanuja SP. Synergistic effect of silymarin and standardized extract of Phyllanthus amarus against CCl4-induced hepatotoxicity in Rattus norvegicus. Phytomedicine 2008;15:1053-61. [PMID: 18848770 DOI: 10.1016/j.phymed.2008.08.002] [Cited by in Crossref: 39] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]